Famar in DCAT Week 2018
Famar will be attending DCAT Week 2018, held in New York City this March.
Famar Appoints Ian Muir as Chief Executive Officer
Paris, 14 November 2017 – Famar, one of Europe’s leading providers of contract manufacturing and development services to the pharmaceutical and health & beauty industries, has today announced that Ian Muir has been appointed CEO of the group, effective from 20 November.
Meet Famar in CPhI 2017 in Frankfurt!
We will be happy to welcome you to Famar booth 41F50 at Hall 4.1. Date Tuesday October 24th to Thursday October 26th, 2017 Location Messe Frankfurt Ludwig-Erhard-Anlage 60327 Frankfurt a. M. Germany
Pillarstone completes first Greek transaction
Pillarstone, the pan-European platform to support banks in managing exposures to non-core and underperforming assets, has announced that Famar will be the first transaction of its Greek platform.
Famar is announcing our participation at CPhI NA 2017
We are excited to announce our participation in one more top event of the pharmaceutical industry, CPhI North America.
FAMAR expands manufacturing footprint into North America
Famar today announces the closing of the acquisition of a manufacturing site from Bayer, located at Pointe-Claire, Canada, with the transfer of full ownership of the plant to Famar.
Famar is announcing our participation at D-CAT Week 2017
As part of Famar’s growth strategy and offering new business opportunities to its customers, we are excited to announce our participation at D-CAT Week 2017
Famar announces its acquisition of Pointe Claire
Famar announces the acquisition of their first manufacturing site in North America
Ecovadis 2016 Assessment
Pleased to announce that Famar Group has been awarded for the 2nd consecutive year at the Silver level by Ecovadis
Ecovadis Gold Recognition
Ecovadis Gold Recognition for two Famar sites